Grasping at straws: the failure of solanezumab to modify mild Alzheimer’s disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Grasping at straws: the failure of solanezumab to modify mild Alzheimer’s disease
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 18, Issue 12, Pages 1189-1192
Publisher
Informa UK Limited
Online
2018-10-31
DOI
10.1080/14712598.2018.1543397
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults
- (2018) Nancy J. Donovan et al. AMERICAN JOURNAL OF PSYCHIATRY
- ABBY
- (2018) Jeffrey L. Cummings et al. NEUROLOGY
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
- (2017) Michael C. Donohue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Efficacy and safety of anti-amyloid-β immunotherapy for Alzheimer's disease: a systematic review and network meta-analysis
- (2017) Jia-Jie Mo et al. Annals of Clinical and Translational Neurology
- Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
- (2016) Eric R. Siemers et al. Alzheimers & Dementia
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- The case for rejecting the amyloid cascade hypothesis
- (2015) Karl Herrup NATURE NEUROSCIENCE
- Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
- (2015) Erik S Musiek et al. NATURE NEUROSCIENCE
- Amyloid-β11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
- (2015) Enchi Liu et al. NEUROLOGY
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
- (2012) Martin Farlow et al. Alzheimers & Dementia
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now